Logo

ArcherDx VariantPlex Solid Tumor Panel

Jun 01, 2015

ArcherDx has launched the VariantPlex Solid Tumor Panel, a targeted next-generation sequencing-based assay to detect somatic variants in 67 cancer-associated genes. Archer VariantPlex assays use the company's anchored multiplex PCR (AMP) technology to capture and amplify sections of the genome frequently mutated in cancers. AMP libraries have greater target recovery from short fragments, making the technology ideal for low-input formalin-fixed, paraffin-embedded samples, ArcherDx said.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.